Evidence map›Paper›PMID 27436084›Full record

ArticleBiological psychiatry2016

Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice.

Kristen K Ade, Yehong Wan, Harold C Hamann, Justin K O'Hare, Weirui Guo, Anna Quian, Sunil Kumar, Srishti Bhagat, Ramona M Rodriguiz, William C Wetsel and 4 more

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Sapap3Translational psychiatry · 2023
    Article
  15. Review
  16. Midbrain dopamine neurons arbiter OCD-like behavior.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Altered Expression andCurrent neuropharmacology · 2022
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Kristen K AdeDepartments of Neurology, Duke University Medical Center, Durham, North Carolina; Neurobiology, Duke University Medical Center, Durham, North Carolina.
Yehong WanDepartments of Neurology, Duke University Medical Center, Durham, North Carolina; Neurobiology, Duke University Medical Center, Durham, North Carolina.
Harold C HamannDepartments of Neurology, Duke University Medical Center, Durham, North Carolina; Neurobiology, Duke University Medical Center, Durham, North Carolina.
Justin K O'HareDepartments of Neurology, Duke University Medical Center, Durham, North Carolina; Neurobiology, Duke University Medical Center, Durham, North Carolina.
Weirui GuoDepartment of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas.
Anna QuianDepartments of Neurology, Duke University Medical Center, Durham, North Carolina.
Sunil KumarPsychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Srishti BhagatDepartments of Neurology, Duke University Medical Center, Durham, North Carolina; Neurobiology, Duke University Medical Center, Durham, North Carolina.
Ramona M RodriguizPsychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
William C WetselPsychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
P Jeffrey ConnDepartment of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
Kafui DzirasaPsychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Kimberly M HuberDepartment of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas.
Nicole CalakosDepartments of Neurology, Duke University Medical Center, Durham, North Carolina; Neurobiology, Duke University Medical Center, Durham, North Carolina. Electronic address: nicole.calakos@duke.edu.
Duke Medical Center · USDuke University Hospital · USThe University of Texas Southwestern Medical Center · USVanderbilt University Medical Center · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
REGULATION OF SIGNALING BY MGLUR5R01MH062646 · NIMH · VANDERBILT UNIVERSITY · PI P Jeffrey Conn, COLLEEN M NISWENDER · 2001 to 2026
$10.9M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Mechanisms of mGluR-dependent synaptic plasticityR01NS045711 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI HUBER, KIMBERLY M. · 2003 to 2015
$4.6M
Basic Predoctoral Training in NeuroscienceT32GM008441 · NIGMS · DUKE UNIVERSITY · PI MCNAMARA, JAMES O. · 1992 to 2017
$4.4M
Cortico-striatal synaptic defects and compulsive motor behaviors in miceR01NS064577 · NINDS · DUKE UNIVERSITY · PI CALAKOS, NICOLE · 2008 to 2017
$3.8M
Functions of Metabotropic Glutamate Receptor SubtypesR37NS031373 · NINDS · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2014 to 2020
$3.5M
Training in Fundamental &Translational NeuroscienceT32NS051156 · NINDS · DUKE UNIVERSITY · PI MCNAMARA, JAMES O. · 2005 to 2014
$2.1M
NICHD NIH HHS U54 HD083211NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM008441NIMH NIH HHS R01 MH062646NINDS NIH HHS R01 NS045711NINDS NIH HHS R01 NS064577NINDS NIH HHS R37 NS031373NINDS NIH HHS T32 NS051156
6 · The paper itself

Abstract

backgroundDevelopment of treatments for obsessive-compulsive disorder (OCD) is hampered by a lack of mechanistic understanding about this prevalent neuropsychiatric condition. Although circuit changes such as elevated frontostriatal activity are linked to OCD, the underlying molecular signaling that drives OCD-related behaviors remains largely unknown. Here, we examine the significance of type 5 metabotropic glutamate receptors (mGluR5s) for behavioral and circuit abnormalities relevant to OCD.

methodsSapap3 knockout (KO) mice treated acutely with an mGluR5 antagonist were evaluated for OCD-relevant phenotypes of self-grooming, anxiety-like behaviors, and increased striatal activity. The role of mGluR5 in the striatal circuit abnormalities of Sapap3 KO mice was further explored using two-photon calcium imaging to monitor striatal output from the direct and indirect pathways. A contribution of constitutive signaling to increased striatal mGluR5 activity in Sapap3 KO mice was investigated using pharmacologic and biochemical approaches. Finally, sufficiency of mGluR5 to drive OCD-like behavior in wild-type mice was tested by potentiating mGluR5 with a positive allosteric modulator.

resultsExcessive mGluR5 signaling underlies OCD-like behaviors and striatal circuit abnormalities in Sapap3 KO mice. Accordingly, enhancing mGluR5 activity acutely recapitulates these behavioral phenotypes in wild-type mice. In Sapap3 KO mice, elevated mGluR5 signaling is associated with constitutively active receptors and increased and imbalanced striatal output that is acutely corrected by antagonizing striatal mGluR5.

conclusionsThese findings demonstrate a causal role for increased mGluR5 signaling in driving striatal output abnormalities and behaviors with relevance to OCD and show the tractability of acute mGluR5 inhibition to remedy circuit and behavioral abnormalities.

Indexed as

Signal TransductionAnimalsBehavior, AnimalCorpus StriatumExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsGlycineGroomingMiceMice, KnockoutMice, TransgenicNerve Tissue ProteinsNiacinamideObsessive-Compulsive DisorderPyridinesReceptor, Metabotropic Glutamate 53-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridineExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsGlycineGrm5 protein, mousemethyl-(4-carboxyphenyl)glycineN-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamideNerve Tissue ProteinsNiacinamidePyridinesReceptor, Metabotropic Glutamate 5Sapap3 protein, mouseThiazolesCircuitConstitutive activitymGluR5Obsessive-compulsive disorderPositive allosteric modulatorStriatum

Identifiers

PMID27436084
PMCPMC5536332
OpenAlexW2385482058

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.